This week’s research highlights AI-driven revenue beats across software names, continuing multiple compression in some industrial/healthcare leaders, and divergent healthcare catalysts. Analysts emphasize execution risk amid strong top-line momentum — a classic ‘growth at a price’ narrative with important event risk ahead.